Xi'an Haixin Pharmaceutical

Xi'an Haixin Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines. Established in 1993 as a key subsidiary of the Shanghai Haixin Group, the company operates a large-scale production base in the Xi'an High-tech Industries Development Zone. Its product portfolio primarily focuses on gastrointestinal health, cardiovascular diseases, and anti-infective treatments. Key commercial products include generic formulations such as omeprazole, rabeprazole, and amlodipine. The company maintains Good Manufacturing Practice (GMP) certified facilities for various dosage forms, including tablets, capsules, and injections. Xi'an Haixin serves both domestic and international markets, leveraging its parent company's extensive distribution network.